Kreon Travix

Pancreatin, the active ingredient in Kreon Travix, is a pancreatic enzyme replacement therapy presented as an oral dosage form for oral use. It is indicated for patients with exocrine pancreatic insufficiency, cystic fibrosis, and chronic pancreatitis to aid digestion of fats, proteins and carbohydrates.

GNH USA supplies Kreon Travix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kreon Travix provides pancreatic enzymes to support digestive function in conditions characterized by enzyme deficiency.

Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates by supplementing deficient pancreatic enzymes. Cystic fibrosis: enhances nutrient absorption and reduces steatorrhea by providing exogenous lipase, amylase and protease. Chronic pancreatitis: assists in maintaining adequate digestion when pancreatic secretion is compromised.

Kreon Travix may be associated with several adverse reactions.

Common Side Effects: - Abdominal discomfort or cramping - Flatulence or bloating - Diarrhea or loose stools - Nausea or mild vomiting - Constipation - Oily or fatty stools

Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria, or anaphylaxis - Severe abdominal pain indicating possible pancreatitis exacerbation - Intestinal obstruction or blockage - Persistent vomiting or severe dehydration

Before prescribing Kreon Travix, consider the following precautions.

Dose adjustment: tailor the dose to the individual’s digestive response and stool fat content. Monitoring: regularly assess nutritional status, weight gain and stool characteristics. Contraindication: avoid in patients with known hypersensitivity to porcine-derived products. Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. Breastfeeding: exercise caution and monitor the infant for any adverse effects. Store below 25°C: keep in the original pack, protect from moisture.

Kreon Travix can interact with other medications that affect gastric pH or enzyme activity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may bind pancreatic enzymes and reduce their efficacy. - High‑dose proton pump inhibitors: can alter gastric acidity, potentially impairing enzyme activation.

Moderate Interactions (Monitor Closely): - Orlistat: may interfere with fat digestion synergy, requiring dose adjustment. - Broad‑spectrum antibiotics: may alter gut flora, affecting overall digestive enzyme performance. - Oral contraceptives: may modestly increase serum enzyme levels, warranting clinical observation.